Literature DB >> 27197185

miR-339-3p Is a Tumor Suppressor in Melanoma.

Claudia E M Weber1, Chonglin Luo1, Agnes Hotz-Wagenblatt2, Adriane Gardyan1, Theresa Kordaß1, Tim Holland-Letz3, Wolfram Osen1, Stefan B Eichmüller4.   

Abstract

Determinants of invasion and metastasis in cancer remain of great interest to define. Here, we report the definition of miR-339-3p as a novel tumor suppressive microRNA that blocks melanoma cell invasion without affecting cell survival. miR-339-3p was identified by a comprehensive functional screen of a human miRNA mimetic library in a cell-based assay for invasion by the melanoma cell line A375. miR-339-3p was determined as a strong inhibitor of invasion differentially expressed in melanoma cells and healthy melanocytes. MCL1 was defined as a target for downregulation by miR-339-3p, functioning through direct interaction with the 3' untranslated region of MCL1 mRNA. Blocking miR-339-3p by an antagomiR was sufficient to increase melanoma cell invasion, an effect that could be phenocopied by RNAi-mediated silencing of MCL1. In vivo studies established that miR-339-3p overexpression was sufficient to decrease lung colonization by A375 melanoma cells in NSG mice, relative to control cells. Overall, our results defined miR-339-3p as a melanoma tumor suppressor, the levels of which contributes to invasive aggressiveness. Cancer Res; 76(12); 3562-71. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197185     DOI: 10.1158/0008-5472.CAN-15-2932

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the BCL2L11 and BAX Proapoptotic Genes.

Authors:  Tianxiang Hu; Yating Chong; Sumin Lu; Rebecca Wang; Haiyan Qin; Jeane Silva; Eiko Kitamura; Chang-Sheng Chang; LesleyAnn Hawthorn; John K Cowell
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

Review 2.  Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma.

Authors:  Ulrich H Weidle; Simon AuslÄnder; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

Review 3.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

4.  The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.

Authors:  Wenqi Chen; Jinhai Zhang; Huijuan Xu; Jie Dai; Xiaorong Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

5.  Long non‑coding RNA‑DUXAP8 regulates TOP2A in the growth and metastasis of osteosarcoma via microRNA‑635.

Authors:  Ting Yang; Jian Ping Guo; Fan Li; Chao Xiu; Hua Wang; Xian Liang Duan
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

Review 6.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

7.  Piceatannol induced apoptosis through up-regulation of microRNA-181a in melanoma cells.

Authors:  Maotao Du; Zhong Zhang; Tao Gao
Journal:  Biol Res       Date:  2017-10-17       Impact factor: 5.612

Review 8.  MicroRNAs in melanoma development and resistance to target therapy.

Authors:  Luigi Fattore; Susan Costantini; Debora Malpicci; Ciro Francesco Ruggiero; Paolo Antonio Ascierto; Carlo M Croce; Rita Mancini; Gennaro Ciliberto
Journal:  Oncotarget       Date:  2017-03-28

9.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

10.  miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.

Authors:  Jing Zhang; Zhonglin Zhu; Jinxin Sheng; Zhilong Yu; Bin Yao; Kejian Huang; Lisheng Zhou; Zhengjun Qiu; Chen Huang
Journal:  Oncotarget       Date:  2017-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.